Cobblestone Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$5.06M Sell
27,271
-67
-0.2% -$11.5K 0.24% 59
2025
Q2
$4.18M Buy
27,338
+183
+0.7% +$28.1K 0.21% 60
2025
Q1
$4.5M Sell
27,155
-1,806
-6% -$283K 0.25% 56
2024
Q4
$4.19M Sell
28,961
-722
-2% -$112K 0.23% 54
2024
Q3
$4.81M Sell
29,683
-1,844
-6% -$294K 0.27% 51
2024
Q2
$4.61M Sell
31,527
-415
-1% -$61.7K 0.28% 52
2024
Q1
$5.05M Sell
31,942
-335
-1% -$53.3K 0.32% 49
2023
Q4
$5.06M Sell
32,277
-1,304
-4% -$200K 0.33% 49
2023
Q3
$5.23M Sell
33,581
-6,921
-17% -$1.14M 0.39% 47
2023
Q2
$6.7M Sell
40,502
-1,130
-3% -$182K 0.47% 43
2023
Q1
$6.45M Sell
41,632
-739
-2% -$119K 0.48% 44
2022
Q4
$7.48M Sell
42,371
-3,991
-9% -$689K 0.57% 44
2022
Q3
$7.57M Sell
46,362
-353
-0.8% -$59.7K 0.63% 38
2022
Q2
$8.29M Buy
46,715
+3,366
+8% +$600K 0.64% 39
2022
Q1
$7.68M Sell
43,349
-9,740
-18% -$1.66M 0.52% 44
2021
Q4
$9.08M Sell
53,089
-62,099
-54% -$10.2M 0.58% 43
2021
Q3
$18.6M Buy
115,188
+153
+0.1% +$26.1K 1.27% 27
2021
Q2
$19M Sell
115,035
-15,286
-12% -$2.53M 1.28% 26
2021
Q1
$21.4M Buy
130,321
+98
+0.1% +$15.9K 1.56% 17
2020
Q4
$20.5M Buy
130,223
+1,944
+2% +$287K 1.58% 14
2020
Q3
$19.1M Sell
128,279
-5,621
-4% -$832K 1.65% 14
2020
Q2
$18.8M Buy
133,900
+5,353
+4% +$780K 1.7% 13
2020
Q1
$16.9M Sell
128,547
-12,330
-9% -$1.75M 1.82% 12
2019
Q4
$20.6M Sell
140,877
-543
-0.4% -$73.7K 1.86% 12
2019
Q3
$18.3M Sell
141,420
-104
-0.1% -$13.7K 1.82% 12
2019
Q2
$19.7M Buy
141,524
+31,335
+28% +$4.34M 1.78% 10
2019
Q1
$15.4M Buy
110,189
+8,746
+9% +$1.17M 1.44% 17
2018
Q4
$13.1M Sell
101,443
-563
-0.6% -$78.5K 1.35% 20
2018
Q3
$14.1M Buy
102,006
+560
+0.6% +$74.4K 1.33% 18
2018
Q2
$12.3M Buy
101,446
+71
+0.1% +$8.86K 1.22% 20
2018
Q1
$13M Sell
101,375
-606
-0.6% -$81.9K 1.32% 17
2017
Q4
$14.2M Sell
101,981
-1,037
-1% -$144K 1.42% 13
2017
Q3
$13.4M Buy
103,018
+917
+0.9% +$122K 1.65% 10
2017
Q2
$13.5M Buy
102,101
+22,253
+28% +$2.84M 1.76% 9
2017
Q1
$9.95M Buy
79,848
+128
+0.2% +$15.3K 1.32% 21
2016
Q4
$9.19M Buy
79,720
+780
+1% +$90.1K 1.27% 20
2016
Q3
$9.32M Sell
78,940
-2,478
-3% -$301K 1.32% 18
2016
Q2
$9.88M Sell
81,418
-25,403
-24% -$2.89M 1.41% 15
2016
Q1
$11.6M Sell
106,821
-1,571
-1% -$163K 1.69% 11
2015
Q4
$11.1M Buy
108,392
+1,537
+1% +$155K 1.67% 14
2015
Q3
$9.97M Buy
106,855
+422
+0.4% +$40.8K 1.59% 16
2015
Q2
$10.4M Buy
106,433
+16,163
+18% +$1.62M 1.56% 16
2015
Q1
$9.08M Sell
90,270
-28,864
-24% -$2.94M 1.4% 19
2014
Q4
$12.5M Sell
119,134
-2,172
-2% -$229K 2.22% 7
2014
Q3
$12.9M Sell
121,306
-2,387
-2% -$248K 2.39% 8
2014
Q2
$12.9M Sell
123,693
-3,691
-3% -$373K 2.43% 8
2014
Q1
$12.5M Sell
127,384
-1,777
-1% -$165K 2.42% 8
2013
Q4
$11.8M Buy
129,161
+474
+0.4% +$43.7K 2.26% 8
2013
Q3
$11.2M Sell
128,687
-1,011
-0.8% -$90.7K 2.28% 9
2013
Q2
$11.1M Buy
+129,698
New +$11M 2.44% 9

Other funds holding JNJ

Cobblestone Capital Advisors's JNJ Position: Q3 2025 in Review

Cobblestone Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 0.25% in Q3 2025, selling an estimated $11.5K and leaving 27,271 shares worth $5.06M. The position accounts for 0.24% of the portfolio, ranked #59.

Cobblestone Capital Advisors first reported a position in JNJ in Q2 2013 and has held it in 50 quarters since. The position peaked at $21.4M in Q1 2021. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Cobblestone Capital Advisors held 27,271 shares of Johnson & Johnson worth $5.06M as of Q3 2025.
  • Cobblestone Capital Advisors sold 67 Johnson & Johnson shares in Q3 2025, an estimated $11.5K.
  • Johnson & Johnson made up 0.24% of Cobblestone Capital Advisors's portfolio in Q3 2025, its #59 holding.
  • Cobblestone Capital Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 50 quarters since.
  • Cobblestone Capital Advisors's Johnson & Johnson position peaked at $21.4M in Q1 2021.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.